SCHEMBL29567160

SCHEMBL29567160

CC(C)c1cccc(C(C)C)c1-c1cc(Oc2ccccc2)nc(NS(=O)(=O)c2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ TSHR P16473 2/20 0.51
▸ PGR P06401 4/20 0.42
▸ LMNA P02545 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ GPR39 O43194 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ SLC40A1 Q9NP59 2/20 0.41
▸ GAA P10253 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ NAT1 P18440 1/20 0.40
▸ HTT P42858 2/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26810671 1.00 SMN1; SMN2 (0.51) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL24309472 0.89 SMN1; SMN2 (0.48) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL29567420 0.85 SMN1; SMN2 (0.57) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL24310003 0.85 SMN1; SMN2 (0.57) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL26806726 0.83 POLB (0.43) SMN1; SMN2TSHRPGRLMNAGPR39
SCHEMBL26810781 0.83 MAPT (0.50) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL24309474 0.82 MAPT (0.52) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL24309985 0.82 TSHR (0.56) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL26806813 0.81 MAPT (0.61) SMN1; SMN2TSHRPGRLMNAALDH1A1
SCHEMBL24310443 0.80 SMN1; SMN2 (0.61) SMN1; SMN2TSHRPGRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback